NCT04614103Phase 2Recruiting

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Study sponsor: Iovance Biotherapeutics, Inc. · IOVA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2030-12Estimated
Enrollment · participants170Estimated
Source updated2026-06-26Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview